Flex Manager
21219 interim professionals
21219 professionals

 Select

Find similar resumes

Managing Director/CEO/CFO/Transition Manager

Managing Director/CEO/CFO/Transition Manager

Work Experience

Summary of my professional achievements :
• Realized growth (revenues & personnel) of a local start-up company towards a global listed Group;
• Realized value creation (e.g. from local academic research to clinical development in Europe & US);
• Closed strategic corporate partnership transactions & managed several acquisitions;
• Closed significant financing rounds (IPO, private placements and grants) despite tough (market) conditions;
• Designed and lead corporate transition/change processes;
• Realized severe cost reduction while optimizing allocation of limited resources;
• Implemented good corporate governance practices;
• Improved business insight and facilitated fact-based operational & strategic decision making.
 
2011-2016 Director - Business Consultant

• Assist innovative companies in key strategic, corporate finance and financial, legal and fiscal matters, e.g. Promethera Biosciences.
• Board member of S.I.S.E. sa – Walloon Platform for Cell Therapy; Managed all financial, legal, tax & IR matters related to the creation of the Platform; Permanently aligned the Platform to the corporate development and scientific and business needs of its participants (biotechnology companies developing cell therapy products for patients).

2006–2010 UNIBIOSCREEN Novel anti-cancer therapeutics Belgium

CEO (02.2008-12.2010) & CFO (06.2006-12.2010)

Accomplishments and results achieved
• Moved two pre-clinical anti-cancer drug candidates to clinical Phase I, one in the US (IND-FDA) & one in Europe (IMPD-EMEA);
• Closed strategic alliance for late preclinical compound worth $ 31M with US based pharmaceutical company;
• Closed several financing rounds (raised € 8M - private placements and grants) for early-stage pipeline;
• Realized severe cost reduction (Net Result +45%) while optimizing resources’ allocation & starting 2 clinical trials.

Duties and responsibilities
• Lead the transition from a university spin-off towards a professional biotech company;
• Conducted analysis & strategic plan for cancer drug development and discovery activities; defined & managed priorities in line with pharma industry, oncology experts’ and investors’ expectations (value creation); strictly coordinated & monitored progress in development (milestones);
• Negotiated & coordinated all M&A and financing transactions, incl. due diligence work;
• Implemented good corporate governance practices;
• Reported transparent information to BOD and private & public stakeholders, and managed expectations.

2004–2006 ING Leading Bank – Real Estate Development the Netherlands+ROW

Project Manager Sarbanes-Oxley (SOx) Project Manager Legislation

Accomplishments and results achieved
• Improved Compliance of all subsidiaries worldwide with internal (ING Group) and external laws and regulations, including Sarbanes-Oxley, Operational & Information Risk Management, Financial Economic Crime, …

Duties and responsibilities
• Designed & implemented SOx process, from initial set-up (scope, COSO, business/financial processes, risk assessment & definition of key controls to mitigate the risks), through design (set-up & existence) & operating effectiveness testing, including repair plan to remediate deficiencies (Prince 2);
• Prepared & implemented improved processes and communication & support for subsidiaries worldwide on Admin. Organization/Internal Control issues.

2004 EUROCLEAR Intern. Central Securities Depositary - settlement Belgium, France, UK

Data Center Strategy Project Coordinator

Accomplishments and results achieved
• Improved business insight and facilitated fact-based operational & strategic decision making and strict cost control.

Duties and responsibilities
• Costs analysis, financial plan and budget follow-up at Group level;
• Designed roadmap for cost allocation across international entities, providing justification for a manageable cost allocation in the context of financial, regulatory and fiscal constraints.

2001–2003 ERNST & YOUNG Big 4 Professional Services Firm Belgium

Head of the Internal Finance Division (over 30 legal entities, various (sub)service lines)

Accomplishments and results achieved
• Designed and lead change process from local statutory accounting towards a professional finance department with pro-active & international management reporting per business segment and including a treasury department;
• Re-defined business processes and streamlined policies & analytical structure according to international guidelines to prepare E&Y Belgium for E&Y International Global Profit Sharing;

Duties and responsibilities
• Responsible for all finance matters for E&Y Belgium;
• Implemented Global Financial Information System (including PeopleSoft Financials) for Global Profit Sharing;
• Presented results to the local Executive Committee and to E&Y International.


1997–2001 KEYWARE TECHNOLOGIES Brussels, Boston, Singapore
Global software security Company listed on NASDAQ Europe (biometrics for smart cards & access control)

Finance and Administrative Director for the Group

Accomplishments and results achieved
• Managed administrative & financial growth (revenues & personnel) of a start-up IT Company towards a global listed Group, through several critical stages :
⎫ All financing rounds since incorporation (raised > $ 135M);
⎫ Six acquisitions (both in the US & in Europe);
⎫ IPO of a global high tech software security Company on the EASDAQ stock exchange - carried out successfully in June 2000 despite crash of Tech markets. Preparation of information for the beauty contest to select the lead bank (ING, London); due diligence; prospectus writing, business plan & business strategy definition; new reporting & communication rules of a public company; Investor Relations.

Duties and responsibilities
Managed all administrative/legal/HRM activities; responsible for financial analyses, treasury, due diligence exercises related to M&A and financing transactions, business plans, valuations, group-wide management reporting system (USGAAP) and policies & procedures;
Managed integration work to align the acquired companies, to enable tracking & analyzing of KPI’s in the various business units and to make the Group benefit from synergies (to boost revenues and to cut costs).



1997  SWAELEN & C°   Audit firm (GIMV, EU Commission, NGO’s, hospitals) Belgium

Audit Manager
Audited financial statements, provided financial consulting, managed audit teams and trained personnel.



1991-1996  ROGIB-Group        Belgium, USA
Investment Companies with various portfolios (mainly commercial real estate) & related activities

Financial Controller
• Prepared and presented consolidated Group management information & detailed audit reports (profitability studies, audit of current account of managers/founders, analyses & re-negotiation of bank loans & related guarantees, forecasts, business plan) to the BOD, the Audit Committee and the Shareholders to enable them to take appropriate business decisions;
• Analyzed profitability of projects, subsidiary performance & acquisition targets and the effect on profitability of different scenarios to restructure the business; recommended & implemented cost saving measures & improvements (optimized fiscal structure, re-organized & reduced number of offices in Belgium, closed down the office in the US, …); analyzed the return on investments for projects; recommended which investments were preferably to be sold (MBO of construction company), which activities to be terminated (project development) & where to focus commercial activities;
• Developed recommendations and implemented decisions taken to restructure the business;
• (Re)-negotiated bank loans & credit facilities, designed & implemented cash pooling;
• Developed and analyzed business plans for/from new investors/business partners;
• Secretary to the BOD.



1986–1991 KPMG Big 4 audit firm Belgium

Senior Auditor
Conducted audits in various sectors (Energy suppliers, Airports, Food industry, Chemical companies, Insurance companies & Banks) and advised clients on financial statements & financial reporting.



1981-1985 ANTWERPSE DIAMANTBANK Belgium

Finance Department Assistant for 5 consecutive summers - while studying. 


Education

EDUCATION

10.1981 – 06.1986 Master’s Degree in Applied Economic Sciences, from the Antwerp University (U.F.S.I.A.),
with a concentration in Business Economics & Finance.
Thesis project completed with honors on the subject of Belgian taxation for Investment Funds, under the guidance of Professor J. J. Couturier.

01.1988 – 02.1991 Internship with Belgian Institute of Auditors.

1986 – 2011 Numerous national & international seminars and training sessions :
legal & tax matters, HRM, transfer pricing, Corporate Finance matters, Euronext, valuation, export financing & –subsidizing, USGAAP, IAS/IFRS, SOx, ICT matters, …

Degree as expert in valuation of real estate.


AWARDS

• Public Award for ‘Best Pitch’ at the European Venture Contest – Final, in Barcelona, Spain (2007).

• Award for Best Presentation (with 4 other participants) : “le prix de la Meilleure Présentation – pour une excellente proposition d’investissement ou de partenariat et une présentation de qualité” from the CréaWAL forum, in Louvain-la-Neuve, Belgium (2008).


OTHER ACTIVITIES

• Speaker at the BVA Academy organized by the Belgian Venture Association – entrepreneurial testimonial on Venture Capital (2008).

• Panelist at the Benelux Venture Forum, in Ghent, Belgium (2009).

• Panelist and expert judge from the pharma industry and the financial world, to define the winners of the DyoDelta European Life Science Innovation Awards (major investment, the best European Life Science investor, the best Life Science partner and the best partnering deal in the industry) hosted by the 9th Annual Biotech Investor Forum, in Zürich, Switzerland (2009) & hosted by the 3rd Annual European Life Science CEO Forum, in Zürich, Switzerland (2010).

• Expert reviewer Life Sciences at the Nordic Venture Forum, in Copenhagen, Denmark (2009), at BIOSPAIN Investment Forum, in Pamplona, Spain (2010) and at the European Venture Contest Semi-Final during INNOVACT, in Reims, France (2010 & 2011).

• Moderator and expert reviewer Life Sciences at the CIVICA European Venture Contest Semi-Final, in Belgium and in Luxembourg (2011).

• Expert reviewer Life Sciences at the AAL Venture Days, in the Netherlands (2012).

• Roundtable moderator at the Clinical Operations in Oncology Trials Conference, in Belgium (2012).

Languages

Dutch, English, French

 Select

Candidate search for

interimmanagementPaste your project description here